Adam Jona

Debrecen, HB 4032, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Bispecific Antibodies in B-Cell Lymphomas: Mechanisms, Efficacy, Toxicity, and Management.

Bispecific Antibodies in B-Cell Lymphomas: Mechanisms, Efficacy, Toxicity, and Management.

Journal: Medicina (Kaunas, Lithuania)

Published: January 06, 2026

Sequencing Cellular Therapies in the Management of Follicular Lymphoma.

Sequencing Cellular Therapies in the Management of Follicular Lymphoma.

Journal: Cells

Published: September 08, 2025

Response Duration During Treatment of Patients with Follicular Lymphoma.

Response Duration During Treatment of Patients with Follicular Lymphoma.

Journal: Biomedicines

Published: April 28, 2025

Prognostication of Follicular Lymphoma: A Review of Prognostic Scores and Factors.

Prognostication of Follicular Lymphoma: A Review of Prognostic Scores and Factors.

Journal: Diagnostics (Basel, Switzerland)

Published: January 27, 2025

Anti-inflammatory 25(OH)D3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia.

Anti-inflammatory 25(OH)D3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia.

Journal: Cell death & disease

Published: November 27, 2024

Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience.

Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience.

Journal: Cancers

Published: November 06, 2024

Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis.

Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis.

Journal: Annals of hematology

Published: April 07, 2024

Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma.

Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma.

Journal: The Journal of international medical research

Published: February 07, 2024

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Journal: Journal of internal medicine

Published: June 01, 2023

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study.

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study.

Journal: Journal of hematology

Published: October 12, 2021

Clinical and biological prognostic factors in follicular lymphoma patients.

Clinical and biological prognostic factors in follicular lymphoma patients.

Journal: PloS one

Published: June 28, 2021

Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.

Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.

Journal: Histopathology

Published: September 13, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026